title: In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(beta benzyl L aspartate) micelles.
abstract: Amphotericin B (AmB) is a membrane-active drug used frequently for the treatment of systemic fungal diseases. Limitations for the use of AmB include poor water solubility and potential for serious systemic toxicities. Recently, it has been demonstrated that the aggregation state of AmB is a determinant factor for toxicity. To increase its therapeutic index, AmB has been solubilized in micelles based on poly(ethylene oxide)-block-poly(beta-benzyl-l-aspartate) (PEO-block-PBLA), using a dialysis method of drug loading. The aggregation state of AmB has been investigated by electronic absorption spectroscopy. AmB loaded in PEO-block-PBLA micelles is non-hemolytic for concentrations up to 15 microgram/ml. AmB as Fungizone(R) initiates hemolysis at 1.0 microgram/ml. The onset of hemolysis correlates with the respective critical aggregation concentrations (CACs) of AmB. The antifungal activity of the AmB-loaded PEO-block-PBLA micelles is four to eight times higher than Fungizone(R) in terms of minimal inhibitory concentrations (MICs). PEO-block-PBLA has no antifungal activity for concentrations up to 200 microgram/ml. The basis for the increase in antifungal activity of AmB-loaded PEO-block-PBLA micelles is unclear, but may be related to a stabilizing effect of the polymeric micelles against auto-oxidation of the AmB heptaene moiety or alternatively, an enhancement in membrane perturbation of fungal cells.
authors.affiliation: 425 N. Charter Street, School of Pharmacy, University of Wisconsin, Madison, WI 53706-1515, USA.
authors.forename: B G
authors.initials: BG
authors.lastname: Yu
authors.forename: T
authors.initials: T
authors.lastname: Okano
authors.forename: K
authors.initials: K
authors.lastname: Kataoka
authors.forename: S
authors.initials: S
authors.lastname: Sardari
authors.forename: G S
authors.initials: GS
authors.lastname: Kwon
mesh_terms: D000666:Amphotericin B / Q000008:administration & dosage* / Q000737:chemistry*; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000737:chemistry*; D003692:Delayed-Action Preparations; D004912:Erythrocytes / Q000187:drug effects; D005079:Excipients / Q000008:administration & dosage* / Q000737:chemistry*; D008297:Male; D008823:Micelles; D008826:Microbial Sensitivity Tests; D010455:Peptides / Q000008:administration & dosage* / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000008:administration & dosage* / Q000737:chemistry*; D011108:Polymers; D051381:Rats; D017207:Rats, Sprague-Dawley; D013056:Spectrophotometry, Ultraviolet
chemical_list: D000935:Antifungal Agents; D003692:Delayed-Action Preparations; D005079:Excipients; D008823:Micelles; D010455:Peptides; D011108:Polymers; C094116:poly(ethylene oxide-co-beta-benzyl-L-aspartate); D011092:Polyethylene Glycols; D000666:Amphotericin B